Page last updated: 2024-08-24

zileuton and Stomach Neoplasms

zileuton has been researched along with Stomach Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Duan, P; Lin, J; Long, J; Tang, J; Zhang, C; Zhu, H	1

Other Studies

1 other study(ies) available for zileuton and Stomach Neoplasms

Article	Year
ALOX5-5-HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation. Cancer medicine, 2021, Volume: 10, Issue:15 Topics: Analysis of Variance; Antineoplastic Agents; Arachidonate 5-Lipoxygenase; Cell Proliferation; Cell Survival; Disease Progression; Humans; Hydroxyeicosatetraenoic Acids; Hydroxyurea; Lipoxygenase Inhibitors; MAP Kinase Signaling System; Phosphorylation; Stomach Neoplasms; Up-Regulation	2021

Article

Year

ALOX5-5-HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation.

Cancer medicine, 2021, Volume: 10, Issue:15

Topics: Analysis of Variance; Antineoplastic Agents; Arachidonate 5-Lipoxygenase; Cell Proliferation; Cell Survival; Disease Progression; Humans; Hydroxyeicosatetraenoic Acids; Hydroxyurea; Lipoxygenase Inhibitors; MAP Kinase Signaling System; Phosphorylation; Stomach Neoplasms; Up-Regulation

2021